Would you like to meet with a federal agency regarding a product you are developing?
Create a meeting request regarding Vaccine-related products and services.
Create a meeting request regarding Diagnostic-related products and services.
Create a meeting request regarding Therapeutic-related products and services.
Create a meeting request regarding Other products and services.
Latest news releases related to medical countermeasures
A therapeutic to treat novel coronavirus disease 2019 (COVID-19) is moving forward in development through a partnership between BARDA, the Department of Defense Joint Program Executive Office for Chemical, Biological, Radiological, & Nuclear Defense, & SAb Biotherapeutics, Inc.
Full ReleaseTreatment and prevention options, including therapeutics, antiviral drugs and vaccines, are critically needed to mitigate 2019 novel coronavirus infections (COVID-19).
Full ReleaseBARDA and Moderna will collaborate to accelerate the development of SARS-CoV-2 mRNA-1273 vaccine which includes non-clinical development and advanced clinical studies, regulatory support through licensure and process development for manufacturing.
Full ReleaseNational, PHEMCE, BARDA, and countermeasure specific strategies, implementation plans, and reports
Our nation faces diverse and evolving health security threats that have the potential to disrupt our public health and health care systems and inflict injury and loss...
It is a vital interest of the United States to manage the risk of biological incidents. In today’s interconnected world, biological incidents have the potential to cost...
The U.S. continues to face a range of serious threats to its health security from the unintentional release or deliberate use of chemical, biological, radiological...
Considering the progress achieved and the remaining strategic gaps in MCM preparedness, the PHEMCE annually examines the SIP goals and objectives...
The goal of the 2016 PHEMCE Stakeholders Workshop was to provide a forum within which a broad spectrum of stakeholders in the PHEMCE mission...
The United States (U.S.) continues to face a range of serious threats to its national health security from the deliberate use or accidental release of chemical...
Significant progress was made in 2014 in the regulatory review and approval of MCMs procured under Project BioShield.
The United States continues to face a range of serious threats to its national health security from the deliberate use or accidental release of chemical, biological...
The Project BioShield Act of 2004 [Project BioShield (PBS); Public Law [P.L.] 108-276] amended the Public Health Service (PHS) Act and the Federal Food...
The Medical Countermeasures (MCM) Enterprise had a significant year in 2012. The U.S. Department of Health and Human Services' (HHS) continued to leverage...
The 2012 Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) Implementation Plan describes the priorities that HHS, in collaboration with its...
The U.S. Government has a responsibility to protect the health and safety of its citizens. The American people continue to face a host of national health...
The nation has endeavored over the past ten years to become better prepared for the medical consequences of catastrophic events such as bioterrorist events...
The medical countermeasures pipeline has never held more promise than it does today. Innovation, enhanced partnerships and collaboration, and sustained...
Emerging infectious diseases, pandemics, and bioterrorism carry the potential for catastrophic impact, and the U.S. government has faced chronic challenges in...
Agencies which coordinate Federal efforts to enhance preparedness for medical countermeasures (MCM) for chemical, biological, radiological and nuclear threats (CBRN), emerging infectious diseases (EID), medical devices, etc.
